Zobrazeno 1 - 10
of 95
pro vyhledávání: '"E, Freireich"'
Autor:
A, Aguayo, H, Kantarjian, T, Manshouri, C, Gidel, E, Estey, D, Thomas, C, Koller, Z, Estrov, S, O'Brien, M, Keating, E, Freireich, M, Albitar
Publikováno v:
Blood. 96:2240-2245
Angiogenesis has been associated with the growth, dissemination, and metastasis of solid tumors. The aims of this study were to evaluate the vascularity and the levels of angiogenic factors in patients with acute and chronic leukemias and myelodyspla
Publikováno v:
Archives of Pathology & Laboratory Medicine. 124:92-97
Objective.—Terminal deoxynucleotidyl transferase (TdT) is a useful marker in the diagnosis of acute lymphoblastic leukemia (ALL) (French-American-British [FAB] L1 and L2) and is most useful in distinguishing ALL from mature B-lymphoid neoplasms, su
Autor:
M, de Lima, S S, Strom, M, Keating, H, Kantarjian, S, Pierce, S, O'Brien, E, Freireich, E, Estey
Publikováno v:
Blood. 90:4719-4724
Chemotherapy produces extended remissions, and potential cures, in a small minority of patients with acute myeloid leukemia (AML). We explored whether potentially cured patients were at increased risk of subsequent invasive cancer and were able to re
Autor:
S, Verstovsek, H, Kantarjian, A, Aguayo, T, Manshouri, E, Freireich, M, Keating, E, Estey, M, Albitar
Publikováno v:
British journal of haematology. 114(2)
Human angiogenin is a potent inducer of angiogenesis. The association between angiogenin and cancer progression and poor outcome in solid tumours has been documented, but its significance in leukaemias has not been evaluated. We evaluated plasma angi
Publikováno v:
Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis. 4(2)
Autor:
M A, Haidar, H, Kantarjian, T, Manshouri, C Y, Chang, S, O'Brien, E, Freireich, M, Keating, M, Albitar
Publikováno v:
Cancer. 88(5)
Loss of heterozygosity (LOH) at the ATM gene (mutated in ataxia telangiectasia [AT] patients) and ATM protein deficiency occur in 14% and 34%, respectively, of patients with chronic lymphocytic leukemia (CLL). ATM protein deficiency also is associate
Autor:
S, O'Brien, H, Kantarjian, C, Koller, E, Feldman, M, Beran, M, Andreeff, S, Giralt, B, Cheson, M, Keating, E, Freireich, M B, Rios, M, Talpaz
Publikováno v:
Blood. 93(12)
Homoharringtonine (HHT) is a novel plant alkaloid that produced a complete hematologic remission (CHR) in 72% of patients with late chronic phase chronic myelogenous leukemia (CML). Cytogenetic (CG) remissions were noted in 31%. In this study, six co
Autor:
P, Starostik, T, Manshouri, S, O'Brien, E, Freireich, H, Kantarjian, M, Haidar, S, Lerner, M, Keating, M, Albitar
Publikováno v:
Cancer research. 58(20)
The gene mutated in ataxia telangiectasia, ATM, on human chromosome 11q22-q23 is implicated in cell cycle control and DNA repair. Ataxia telangiectasia patients as well as ATM-deficient mice are immune deficient and develop lymphoproliferative diseas
Publikováno v:
Cancer research. 52(15)
We examined the effects of CI-973 (supplied by Parke-Davis) on several human leukemia cell lines and a Chinese hamster ovary (CHO) line and their drug-resistant counterparts. The cell lines used were HL-60, HL-60/mAMSA, HL-60/DOX, KBM3, KBM3/mAMSA 6,
Autor:
E. Freireich
Publikováno v:
Leukemia Research. 31:S31